Preparation and Characterization of 10-Hydroxycamptothecin Loaded Nanostructured Lipid Carriers

REFERENCES

• Abdelwahed W., Degobert G., Stainmesse S., Fessi H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv. Drug Deliv. Rev. 2006; 58: 1688–1713
   PubMed Web of Science ®Google Scholar
• Allen C., Maysinger D., Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf. B Biointerfaces 1999; 16: 3–27
   Web of Science ®Google Scholar
• Arica-Yegin B., Benoit J. P., Lamprecht A. Paclitaxel-loaded lipid nanoparticles prepared by solvent injection or ultrasound emulsification. Drug Dev. Ind. Pharm. 2006; 32(9)1089–1094
   PubMed Web of Science ®Google Scholar
• Carbonero R., Supko J. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin Cancer Res. 2002; 8: 641–661
   PubMed Web of Science ®Google Scholar
• Cortesi R., Esposito E., Maietti A., Menegatti E., Nastruzzi C. Formulation study for the antitumor drug camptothecin: Liposomes, micellar solutions and a microemulsion. Int. J. Pharm. 1997; 159: 95–103
   Web of Science ®Google Scholar
• Ertl B., Platzer P., Wirth M., Gabor F. Poly(D, L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin. J. Controlled Rel. 1999; 61: 305–317
   PubMed Web of Science ®Google Scholar
• Garcia-Fuentes M., Aolores M. J., Torres D. Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures. J. Colloid Interface Sci. 2005; 285(2)590–598
   PubMed Web of Science ®Google Scholar
• Gref R., Minamitake Y., Peracchia M. T., Trebetskoy V. S., Torchilin V. P., Langer R. Biodegradable long-circulating polymeric nanospheres. Science 1994; 263: 1600–1603
   PubMed Web of Science ®Google Scholar
• Hatefi A., Amsden B. Camptothecin delivery methods. Pharm. Res. 2002; 19: 1389–1399
   PubMed Web of Science ®Google Scholar
• Hung C. F., Fang C. L., Liao M. H., Fang J. Y. The effect of oil components on the physicochemical properties and drug delivery of emulsions: Tocol emulsion versus lipid emulsion. Int. J. Pharm. 2007; 335: 193–202
   PubMed Web of Science ®Google Scholar
• Jaxel C., Kohn K. W., Wani M. C., Wall M. E., Prommier Y. Structure-acticvity study of the actions of camptothecin derivatives on mammalian topoisomerase I: Evidence for a specific receptor site and for a relation to antitumor activity. Cancer Res. 1989; 49: 1465–1469
   PubMed Web of Science ®Google Scholar
• Joshi M., Patravale V. Formulation and evaluation of Nanostructured Lipid Carrier (NLC)-based gel of Valdecoxib. Drug Dev. Ind. Pharm. 2006; 32(8)911–918
   PubMed Web of Science ®Google Scholar
• Konan Y. N., Gurny R., Allémann E. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int. J. Pharm. 2002; 233: 239–252
   PubMed Web of Science ®Google Scholar
• Lee M. K., Lim S. J., Kim C. K. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 2007; 28: 2131–2146
   Google Scholar
• Liu J., Zhu J., Du Z., Qin B. Preparation and pharmacokinetic evaluation of Tashinone.II. A solid lipid nanoparticles. Drug Dev. Ind. Pharm. 2005; 31(6)551–556
   PubMed Web of Science ®Google Scholar
• Malzert-Freon A., Vrignaud S., Saulnier P., Lisowski V., Benoit J. P., Rault S. Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent. Int. J. Pharm. 2006; 320: 157–164
   PubMed Web of Science ®Google Scholar
• Müller R. H., Madar K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur. J. Pharm. Biopharm. 2000; 50: 161–177
   PubMed Web of Science ®Google Scholar
• Müller R. H., Mehnert W., Lucks J. S., Schwarz C., zur Muhlen A., Weyhers H., Freitas C., Ruhl D. Solid lipid nanoparticles-an alternative collidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 1995; 41: 62–69
   Web of Science ®Google Scholar
• Müller R. H., Radtke M., Wissing S. A. Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 2002a; 242: 121–128
   PubMed Web of Science ®Google Scholar
• Müller R. H., Radtke M., Wissing S. A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 2002b; 54: S131–S155
   PubMed Web of Science ®Google Scholar
• O'Leary J., Muggia F. M. Camptothecins: A review of their development and schedules of administration. Eur. J. Cancer 1998; 34: 1500–1508
   PubMed Web of Science ®Google Scholar
• Potmesil M. Camptothecins: From bench research to hospital wards. Cancer Res. 1994; 54: 1431–1439
   PubMed Web of Science ®Google Scholar
• Pouton C. W. Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur. J. Pharm. Sci. 2000; 11: S93–S98
   PubMed Web of Science ®Google Scholar
• Schubert M. A., Müller-Goymann C. C. Characterisation of surface-modified solid lipid nanoparticles (SLN): Influence of lecithin and nonionic emulsifier. Eur. J. Pharm. Biopharm. 2005; 61: 77–86
   PubMed Web of Science ®Google Scholar
• Shenderova A., Burke T., Schwendeman S. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles. Pharm. Res. 1997; 14: 1406–1414
   PubMed Web of Science ®Google Scholar
• Tong W., Wang L., D'Souza M. J. Evaluation of PLGA microspheres as delivery system for antitumor angent-camptothecin. Drug Dev. Ind. Pharm. 2003; 29(3)745–756
   PubMedGoogle Scholar
• Wall M. E., Wani M. C., Cook C. E., Palmer K. H., McPhail A. T., Sim G. A. Plant antitumor agents. I. The isolation and structureof camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminate. J. Am. Chem. Soc. 1966; 88: 3888–3890
   Web of Science ®Google Scholar
• Yang S. C., Zhu J. B. Preparation and characterization of camptothecin solid lipid nanoparticles. Drug Dev. Ind. Pharm. 2002; 28(3)265–274
   PubMed Web of Science ®Google Scholar
• Zhang C., Ding Y., Yu L. L., Ping Q. N. Polymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivatives. Colloids Surf. B. Biointerfaces 2007; 55: 192–199
   PubMed Web of Science ®Google Scholar
• Zhang L. Y., Yang M., Wang Q., Li Y., Guo R., Jiang X., Yang C. Z., Liu B. R. 10-hydroxycamptothecin loaded nanoparticles: Preparation and antitumor activity in mice. J. Control. Rel. 2007; 119: 153–162
   PubMed Web of Science ®Google Scholar
• Zhang J., Xuan T., Parmar M., Ma L., Ugwu S., Ali S., Ahmad I. Development and characterization of a novel liposome-based formulation of SN-38. Intl. J. Pharm. 2004; 270: 93–107
   PubMed Web of Science ®Google Scholar